Beckman Coulter, Inc.
 

Our Company
 
Company Profile
 
Investor Relations

Press Room
 
Community Relations
 
Our Heritage
   
   
   
   
   
   
   
   
 
 

Press Releases Printer Friendly

Beckman Coulter, Inc. to Distribute CompuCyte Laser Scanning Cytometers
Agreement bolsters substantive cellular analysis product line

Orange County, Calif. (December 11, 2009) – Beckman Coulter, Inc. and CompuCyte Corporation have entered into a five-year global distribution agreement, under the terms of which Beckman Coulter will have the right to distribute CompuCyte laser scanning cytometers in cellular analysis markets worldwide. Beckman Coulter will maintain exclusive distribution rights for CompuCyte iGeneration technology outside of North America, and will share with CompuCyte the right to sell the instrumentation to research institutions and pharmaceutical companies within the U.S., Canada and Mexico. CompuCyte will continue worldwide direct sales of LSC instrumentation for automated tissue analysis.

"This agreement provides us with a sophisticated imaging platform that nicely complements our growing flow cytometry product portfolio," stated Brad Calvin, Beckman Coulter vice president for flow cytometry. "The iGeneration line of imaging cytometers will be an important addition to the range of products we are launching. This will enable us to provide researchers around the world with a broad range of technology for cell-based research from a single service provider, while further demonstrating our commitment to the research market."

Dr. Elena Holden, CompuCyte president and CEO, welcomed the new agreement: "Our distribution alliance is built on a great synergy between the two companies. Beckman Coulter is a renowned leader in flow cytometry instrumentation and CompuCyte is recognized as the first company to introduce solid-phase imaging cytometry technology (LSC) to the marketplace. LSC technology is complementary to flow cytometry and applies similar analysis principles to adherent cellular and tissue specimens, combining the resulting analytic data with high-quality imaging. The agreement with Beckman Coulter furthers CompuCyte’s commitment to the growing quantitative imaging cytometry market by enlarging the LSC technology distribution channel, and by bringing outstanding technical support to our customers worldwide."

About Beckman Coulter
Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits and operating-type lease payments, represents approximately 78 percent of the company's 2008 annual revenue of $3.1 billion. For more information, visit www.beckmancoulter.com.

About CompuCyte Corp.
CompuCyte Corporation, a privately held corporation headquartered in Westwood, Massachusetts, is a pioneer in the field of quantitative imaging cytometry (QIC). The company’s comprehensive line of laser scanning cytometry instrumentation is applied to automated cellular and tissue analysis in life science research, drug safety, toxicology studies and clinical trials. Committed to educational programs and promotion of the science and practice of LSC technology, CompuCyte actively maintains the International QIC Centers of Excellence program (www.imagingcytometrycenter.com) and the annual International QIC Symposium. More information about CompuCyte Corporation and its technology may be found at www.compucyte.com.

Beckman Coulter and the stylized logo are registered trademarks of Beckman Coulter, Inc.

 
   
Back to Press Releases Top of Page